New diagnoses of prostate cancer decreased according to study from MPH alum
New prostate cancer diagnoses declined by almost 30% in the first year after the U.S. Preventive Services Task Force (USPSTF) recommended against routine screening PSA tests, a review of a national database showed. An analysis by disease stage at diagnosis showed that the number of new diagnoses of intermediate- and high-risk prostate cancer also decreased, which could have potentially ominous implications if the trend persists, Daniel A. Barocas, MD, of Vanderbilt University in Nashville, Tenn., and co-authors concluded in a report in the December issue of the Journal of Urology.